Influence of Ozone Therapy on Postoperative Pain Relief in the Surgical Treatment of Lower Third Molars: Randomized Controlled Trial

Sponsor
Azienda Ospedaliera Ordine Mauriziano di Torino (Other)
Overall Status
Recruiting
CT.gov ID
NCT05949476
Collaborator
(none)
55
1
2
12
4.6

Study Details

Study Description

Brief Summary

Patients will undergo a split-mouth protocol which includes:

a control group: in which the extraction of the lower third molar will be performed according to the standard protocols of the structure.

A study group: in which ozone will be used in addition, in two formulations: gaseous, injected into the site of the pre- and post-surgery operation, and topical, in the form of a gel, applied at the end of the operation and for home use according to therapeutic scheme prescribed at the time of discharge.

Primary objective: To evaluate whether the use of ozone in patients undergoing extraction of impacted third molars reduces post-operative pain 7 days after surgery.

Secondary objectives:
  • Evaluate the functional limitation in opening the mouth (trismus) 7 days after surgery.

  • Evaluate if there is a reduced intake of analgesic drugs in the 7 days following the operation.

  • Evaluate the perceived quality of life in the 7 days following the intervention.

Condition or Disease Intervention/Treatment Phase
  • Other: ozone therapy
N/A

Detailed Description

Patients will undergo a split-mouth protocol which includes:

a control group: in which the extraction of the lower third molar will be performed according to the standard protocols of the structure.

A study group: in which ozone will be used in addition, in two formulations: gaseous, injected into the site of the pre- and post-surgery operation, and topical, in the form of a gel, applied at the end of the operation and for home use according to therapeutic scheme prescribed at the time of discharge.

Primary objective: To evaluate whether the use of ozone in patients undergoing extraction of impacted third molars reduces post-operative pain 7 days after surgery.

Secondary objectives:
  • Evaluate the functional limitation in opening the mouth (trismus) 7 days after surgery.

  • Evaluate if there is a reduced intake of analgesic drugs in the 7 days following the operation.

  • Evaluate the perceived quality of life in the 7 days following the intervention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
55 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
Influence of Ozone Therapy on Postoperative Pain Relief in the Surgical Treatment of Lower Third Molars: Randomized Controlled Trial
Actual Study Start Date :
Jul 19, 2022
Actual Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Jul 19, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Group

extraction of the lower third molar will be performed according to the standard protocols of the structure

Experimental: Trial Group

In this group ozone will be used, in two formulations: gaseous, injected into the site of the pre- and post-surgery operation, and topical, in the form of a gel, applied at the end of the operation and for home use according to the therapeutic scheme prescribed at the time of resignation

Other: ozone therapy
Ozone in the gaseous state produced by a machine at concentrations for medical use (sssssssssss9) injected after anesthesia in the surgery site and in the post-extraction alveolus after suture. Topical ozone in the form of a gel (indicate the brand) to be applied to the post-surgical site 2 times a day for 7 days.

Outcome Measures

Primary Outcome Measures

  1. Reduction post operative pain [7 days]

    Evaluate whether the use of ozone in patients undergoing extraction of impacted third molars reduces post-operative pain 7 days after surgery.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Lower third molars included

  • Pell-Gregory Class II-B

  • Absence of systemic diseases

Exclusion Criteria:
  • Hyperthyroidism;

  • G6PHD (glucose 6 phosphate dehydrogenase) deficiency;

  • Anemia

  • Myasthenia

  • Pregnancy and breastfeeding

  • Allergy to ozone

  • Local infections

Contacts and Locations

Locations

Site City State Country Postal Code
1 A.O. Ordine Mauriziano Torino Italy 10128

Sponsors and Collaborators

  • Azienda Ospedaliera Ordine Mauriziano di Torino

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Azienda Ospedaliera Ordine Mauriziano di Torino
ClinicalTrials.gov Identifier:
NCT05949476
Other Study ID Numbers:
  • OZONOTERAPIA
First Posted:
Jul 18, 2023
Last Update Posted:
Jul 18, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2023